Ken Banta and Craig Tooman on why the best leaders win by asking better questions — not just chasing more data — and what that means for drug development, funding and AI in the years ahead.
Ken Banta
Advertisement
Founder and CEO of The Vanguard Network, a membership organization that supports and advises CEOs and their senior teams. Banta is former head of strategic affairs at Schering-Plough, Bausch & Lomb, and Pharmacia and helped lead 11 global turnarounds, mergers, and transformations. He began his career as a correspondent/writer with Time Magazine, including as Eastern Europe bureau chief covering the fall of communism and the democratic revolutions of the region.
Banta is the author of “Seeing Around Corners”: C-Suite wisdom from America’s most insightful leaders.
Articles by Ken Banta
Ken Banta and Andy Milligan explore how life sciences leaders can rebuild relevance, consistency, and trust in today's complex and cost-focused era of healthcare.
Ken Banta and Andrew Hall share insights on leading through uncertainty—covering culture, capital, risk, and the regulatory headwinds influencing key decisions in drug development.
A case study in leading and guiding a cultural reset and strategic revival.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
3
Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta
4
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
5